Background: Causes of death related studies in HIV infected population are necessary to devise disease specific preventive interventions at both state and national level HIV programs. This study examines the causes of death among HIV-infected individuals registered at selected Anti-Retroviral Therapy (ART) centers in the era of treatment in north-eastern India. Data and Methods: A retrospective chart review of causes of death was undertaken among HIV-infected patients who were treated between January 2006 and November 2012 at three selected ART centers in Assam, a north-eastern state of India. Reported causes of death were coded as per the guidelines of the International Classification of Diseases (ICD-10) to determine the deaths to standard definitions. Results: Among 5612 HIV-infected patients registered over a period of 71 months, 370 deaths have occurred. Tuberculosis (28%) was the leading cause of death followed by death due to AIDS related complex (11%), wasting syndrome and multiple infections (9% each). Deaths due to selected causes were significantly associated with patient's use of alcohol, WHO clinical stage, CD4 count at the time of diagnosis, presence of opportunistic infections during treatment and ART adherence. Median survival duration was shortest among patients who had CD4 count <50 at the start of ART (2.9 months) and patients who had multiple opportunistic infections during treatment (2.5 months). Discussion: Majority (67%) of deaths in our study were due to AIDS-related causes. Tuberculosis has remained the leading cause of death among the HIV patients on ART. Strengthening the linkages and referral between the HIV and TB program will be crucial to reduce the AIDS-related deaths attributed to tuberculosis.
Introduction
Causes of death related studies among HIV infected population are necessary to devise disease specific preventive interventions in HIV programs. Globally, increase use of antiretroviral therapy (ART) has decreased AIDSrelated deaths to a great extent [1] - [4] . With the inclusion of more effective and tolerable ART regimens, it is important to monitor causes of death and assess associated risk factors. The ART program in India was launched in 2004 and free services were being provided across 230 ART centers across the country [5] . As per National AIDS Control Organization (NACO), fewer AIDS-related deaths have been recorded in 2011 than a decade ago as a consequence of the extensive availability and access to antiretroviral therapy since 2006 in India [6] . A study from southern India reported the decrease in mortality from 25 to 5 deaths per 100 person years among HIV infected individuals between 1997 and 2003 after initiation of ART [7] . A retrospective study from Andhra Pradesh in India conducted over a 14-year period on 2050 HIV-infected patients reported more deaths in highly active antiretroviral therapies (HAART) era as compared to pre HAART era [8] . Although AIDS-related death rates have declined, the associated co-morbidities continue to gain increased attention from the national program. Other published studies from India suggest that HIV-infected individuals are at greater risk of acquiring selected opportunistic infections such as Tuberculosis, oral candidiasis, and other non-communicable diseases increasing their risk for death [9] - [12] . In Southern India reported about 37% of the total deaths among HIV infected individuals were due to AIDS related causes, however, considerable 22% deaths also occurred deaths due to non-AIDS defining malignancies like lung cancer, anal cancer, liver cancer and Hodgkin Lymphoma, liver diseases and multiple organ failure [13] [14] .
The search for literature around detailed descriptions of the causes of death among HIV-infected individuals pointed to few micro level studies in India [5] [7]- [9] , and no studies found from the north-eastern India. More importantly, studies examining the factors associated with selected causes of death are limited in India. We therefore, examine the causes of death and related characteristics among HIV-infected individuals treatment at the ART centers in north-eastern India.
Materials and Methods

Data
A retrospective review of the patient charts was undertaken in the three ART centers located in Assam, a northeastern state of India. All death cases among 5612 HIV patients registered in the three ART centers between January 2006 and November 2012 were included in the study. The causes of death have been individually confirmed by the medical officers of the ART centers following the reporting of death. The patient charts were collected from ART centers where causes of death were written, and they were entered electronically by trained staff and were edited before finalizing the dataset. Since the start of ART centers in Assam in [2005] [2006] , there were a total of 370 deaths recorded over a period of 6 years. The causes of death were classified by using International Classification of Diseases (ICD-10) that includes a single or a combination of causes of death. Further, they were categorized into three major domains as follow:
Wasting syndrome: It is diagnosed in HIV-infected people who have unintentionally lost more than 10% of their body weight and can occur as a result of HIV infection itself but also is commonly associated with HIVrelated opportunistic infections and cancers.
AIDS related complex: It is a complex of signs and symptoms representing a less severe stage of human immunodeficiency virus (HIV) infection, characterized by chronic generalized lymphadenopathy, fever, weight loss, prolonged diarrhea, minor opportunistic infections, cytopenia, and T-cell abnormalities of the kind associated with AIDS.
Other specified condition: It includes combination of signs and symptoms like diarrhea, vomiting, fever, bleeding etc. which have been assigned as the causes of death.
Measures
Along with causes of death among ART patients, other information were also obtained from patient charts included: socio-demographic characteristics, alcohol use (regular, not regular, never and past alcoholic), clinical characteristics such as CD4 count at diagnosis and prior to death (<50, 50 -199, 200 -349 and 350+), WHO clinical stage at the start of ART (stage1, statge2, stage3 and stage4), presence of other opportunistic infections (OIs) and ART adherence during follow-up (>95% and <=95%). The socio-demographic characteristics included in this study are sex (male and female); age (<18 years, 18 -24 years, 25 -34 years, 35 -44 years and 45+ years); education (illiterate, primary, secondary and college and above); occupation (unskilled/agricultural labor, service, business/self-employed and unemployed).
Ethical Considerations
The Assam State AIDS Control Society (ASACS) under the guidance of NACO has provided general oversight and approval for the collection and use of program data for examining the causes of death among ART patients. Patients are informed (as per the guidelines of national ART program in India) at the time of enrollment to ART centers that their medical history may be used for program strengthening. Verbal consent was taken from each patient at the time of enrollment who had agreed to use of their medical history for research purpose. All the patients were explained about the harms and benefits of being enrolled into ART and also their schedule of visits to ART centers. The counselor at the ART center recorded all these procedures. As the data presented in the study are for the purpose of program monitoring and program beneficiaries were informed about this a priori; therefore, the study was determined to be exempted for review from an institutional review board. Strict confidentiality of all the data was maintained and no personal identifiers were included in the analysis.
Statistical Analyses
Univariate, bivariate and multivariate analyses were performed. Percentage distribution of the causes of death was analyzed and death per 100 person years was calculated for the major causes of death. Further the sociodemographic and the clinical characteristics of the death cases were analyzed for the causes of death. To calculate proportions, Chi-square statistics were used and a p-value less than 0.05 were considered statistically significant. The survival time was measured as duration between the date of ART initiation to the reported date of death for patients who died or the date of the last recorded visit for patients who were censored (either alive till the end of the study period or lost to follow-up). Further median duration of survival from initiation of treatment was calculated based on population sub-groups of CD4 count and OIs during treatment. All statistical analyses were performed using SPSS software (version 16.0) [15] .
Results
A total of 370 deaths occurred out of the total 5612 HIV patients who were registered in the three ART centers between January 2006 and November 2012. Among the 370 deaths, Tuberculosis (28%) was the leading cause of death followed by deaths due to AIDS related complex (11%), multiple infections and wasting syndrome (9% each) ( Table 1 & Table 2 ). Two-thirds of the total deaths (247/370) were due to AIDS-related causes, whereas the remaining were either due to non-AIDS related causes or cause of death was unknown (24%). The analysis of the major causes of death by the socio-demographic characteristics (Table 3) shows that in the 18 -34 years age group, Tuberculosis and AIDS related complex were the major causes of death where as in the >35 years age group, multiple infections and wasting syndrome were significant contributors along with Tuberculosis. Among males, Tuberculosis (30%) and AIDS related complex (11%) were the leading causes of death whereas in females, Tuberculosis (23%) and wasting syndrome (16%) were the major contributors. Among regular alcoholics, Tuberculosis (35%) was the leading cause of death although for a significant proportion (46%) of deaths, the cause was unknown. Among past-alcoholics, Tuberculosis (26%) followed by multiple infections and wasting syndrome (18% each) were significant contributors of death. The median CD4 count at the time of diagnosis was highest among those who died of other specified conditions (110) and lowest among those who died of multiple infections (43) whereas the median CD4 count prior to death was highest among those who died of Tuberculosis (108) and lowest among those who died of multiple infections (51). More than 95% adherence to ART was highest among Tuberculosis deaths (23%) and lowest among those who died of other specified conditions (7%). The percentage of having multiple OIs was high among those who died of Tuberculosis (22%), multiple infections (22%) and among those where cause of death is unknown (20%). We found a strong relationship between the patient's use of alcohol prior to death and different causes of death ( Table 3) . For example, among person with daily alcohol use, a greater proportion of deaths were caused by Tuberculosis (35%) as compared to persons with occasional or no alcohol use (26%) (p < 0.001).
Further analysis of the clinical and laboratory characteristics of the death cases (Table 4) shows that almost half of the deaths due to multiple infections (56%), wasting syndrome (49%) and AIDS related complex (45%) had CD4 count < 50 at the time of diagnosis. Also, across all causes of death majority of the cases had CD4 count < 200 at the time of diagnosis. Nearly three-fifths of Tuberculosis deaths (59%) were in WHO clinical stage 4 at the start of ART. Also, across all causes of death, majority of the cases were in WHO clinical stage 3 and 4 at the start of ART. However, significant proportion of cases whose cause of death was wasting syndrome (54%), AIDS related complex (36%) and other causes (46%) were in WHO clinical stage 1 and 2 at the start of ART. Among deaths due to Tuberculosis, Tuberculosis (82%) was the major OI during treatment. Tuberculosis was also the major OI among 37% deaths due to other specified conditions and 35% deaths where the cause of death is unknown. For deaths due to wasting syndrome, other OIs (44%) (e.g. prolong fever, prolong diarrhea, respiratory tract infections, hepatitis virus infection, herpes infections and carcinomas) was the major OI during treatment. WHO clinical stage at the start of treatment was significantly associated with causes of death (p < 0.001) ( Table 4 ). Among deaths due to Tuberculosis, 59% were in WHO clinical stage 4 at the start of treatment.
Similarly, among deaths due to multiple infections, 39% were in WHO clinical stage 4 at the start of treatment.
There was also significant association between the major OIs during treatment and the causes of death (p < 0.001).
Year wise analysis of the causes of death showed that Tuberculosis (30%) was the major cause of death among ART patients each year. It was also seen that deaths due to wasting syndrome and AIDS-related complex had increased in the last three years while there was a declining trend among deaths due multiple infections (Figure 1) . Median duration of survival from treatment initiation to death was calculated based on CD4 at the beginning of ART and major OIs during treatment. The median survival results (Figure 2) suggest that survival duration of patients was inversely proportional to the CD4 count at the initiation of ART. Among patients with OIs during treatment, the longest survival period was among patients with other OIs (5.0 months) and lowest among those who had multiple OIs (2.5 months).
Discussion
The findings of this study indicates that Tuberculosis, AIDS related complex, multiple infections and wasting [17] . The findings of the study add further that the high proportion of deaths due to multiple infections and wasting syndrome is a growing concern. Although majority of deaths have occurred due to AIDS and non-AIDS related causes, a considerable proportion of deaths were also reported where causes are unknown; a finding similar to the previous studies [2] [18]. The proportion of deaths due to unknown causes (24%) in this study is much higher compared to the other studies [19] [20] . It may be due to the causes of death were assigned as reported by the health staff or relatives. However, the deaths due to unknown causes may be also attributable to Tuberculosis as there is similarity in the predictor variables for both the causes (e.g. Use of alcohol, median CD4 count and having multiple infections). This study highlights that the deaths due to different causes are significantly associated with patient's use of alcohol, WHO clinical stage, CD4 count at the time of diagnosis, presence of opportunistic infections during treatment and ART adherence. The study findings illustrate that majority of patients who died with multiple infections which is suggestive of advance AIDS had CD4 count < 200 cells/µL at HIV diagnosis. This finding is consistent with a recent study which highlighted that CD4 at baseline continues to play an important role in predicting deaths due to AIDS [21] . The study describes that 59% of Tuberculosis related AIDS deaths were in WHO Clinical stage 4 at ART initiation, a finding similar to another study which shows WHO clinical stage 4 as an important risk factor for Tuberculosis mortality among HIV infected individuals [22] . The study shows that 82% of the AIDS deaths due to Tuberculosis had Tuberculosis as the major OI during ART while 35% multiple infections related AIDS deaths had multiple OIs during ART.
The study shows a significant association between regular use of alcohol and deaths due to Tuberculosis. Various studies done across the world and India have also shown that use of alcohol increases the risk of Tuberculosis [23] [24] . In addition, both alcohol consumption and HIV infection impairs the host's defense mechanism against Tuberculosis infection and disease [25] [26] . Further, alcohol consumption also affects the adherence to HIV and Tuberculosis treatment. The study indicates that more than half of deaths due to multiple infections (56%) had CD4 count less than 50 at the time of diagnosis which highlights the fact that they have undergone HIV testing at the last stage and had already developed AIDS, a similar finding was noted in other settings [27] [28] . The study also confirms wasting syndrome (9%) as a major cause of mortality. Similar findings have been documented in a study done in Uganda where more than 30% of deaths had occurred due to wasting syndrome [29] . The study findings urge for further research to explore the underlying causes for AIDSrelated mortality due to wasting syndrome in India. The study findings should be interpreted cautiously in light of certain study limitations. First, the causes of death were not based on proper death certificate but as reported by family members and relatives, and assigned by the health officials in ART centers. Second, as this study only included death cases, survival analysis could not be done and only survival duration was calculated. Third, the analysis is limited to the variables that were available in the recorded data. Further research could examine the range of factors associated with causes of death among HIV positive population.
Conclusion
The study demonstrates that AIDS-related causes continue to be the leading causes of deaths among HIV patients in north-eastern India. Among them, Tuberculosis is the leading cause of death. The study also stressed on the fact that there was a need for further research into other causes of death, i.e., due to AIDS-related complex and wasting syndrome. This highlights the need for further strengthening the referral and linkages in the HIVTuberculosis program. In addition, counseling services at the HIV and Tuberculosis care settings should also address the issue of alcohol use by providing appropriate counseling to the patients. The study findings have also important policy implications for ART programs in India. Efforts are required at the management as well as at implementation level for constant and regular follow-up with all HIV patients. Further, this is essential to increase the risk perception as well as to the knowledge about the benefits of ART among these individuals which can increase the adherence level and survival rate. In addition, the program should expand the provision of ART services to more remote areas to provide services to some of the underserved population groups like women and other key population. Proper strategies are required to ensure early diagnosis and enrollment into ART for patients with very low CD4 count. Furthermore, community level sensitization is required to reduce stigma and discrimination towards HIV positive individuals so that patients can access treatment without any hesitation. In addition to that this study strongly recommends further research and advocacy to ensure that disease specific interventions are appropriately addressed in HIV programs and policies.
